Stockscreener 앱 받기
26.02
4.81%
1.1928
전일 마감가:
$24.83
열려 있는:
$24.59
하루 거래량:
497.22K
Relative Volume:
0.34
시가총액:
$2.24B
수익:
$1.13B
순이익/손실:
$62.75M
주가수익비율:
41.31
EPS:
0.63
순현금흐름:
$170.92M
1주 성능:
+6.01%
1개월 성능:
+34.08%
6개월 성능:
+22.82%
1년 성능:
+73.85%
1일 변동 폭
$24.59
$26.02
1주일 범위
$24.43
$27.25
52주 변동 폭
$13.86
$27.25
Progyny Inc Stock (PGNY) Company Profile
명칭
Progyny Inc
전화
212-888-3124
주소
1359 BROADWAY, NEW YORK, NY
PGNY을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PGNY
Progyny Inc
|
26.02 | 2.14B | 1.13B | 62.75M | 170.92M | 0.63 |
|
UNH
Unitedhealth Group Inc
|
321.68 | 282.20B | 435.16B | 18.37B | 17.37B | 19.16 |
|
CVS
Cvs Health Corp
|
78.07 | 96.53B | 393.94B | 428.00M | 6.29B | 0.3826 |
|
CI
Cigna Group
|
279.29 | 72.02B | 268.22B | 6.55B | 7.44B | 22.67 |
|
ELV
Elevance Health Inc
|
323.89 | 69.78B | 194.82B | 5.53B | 3.77B | 24.45 |
|
HUM
Humana Inc
|
231.15 | 26.86B | 123.11B | 1.58B | 2.44B | 13.03 |
Progyny Inc Stock (PGNY) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-12 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-07-08 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2024-12-02 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-11-13 | 다운그레이드 | Truist | Buy → Hold |
| 2024-09-19 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-08-07 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2024-08-07 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2024-08-07 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2024-07-16 | 개시 | JMP Securities | Mkt Outperform |
| 2024-05-10 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-02-26 | 개시 | Leerink Partners | Outperform |
| 2024-01-03 | 개시 | Barclays | Overweight |
| 2023-09-27 | 개시 | Canaccord Genuity | Buy |
| 2023-05-22 | 개시 | BTIG Research | Buy |
| 2023-04-21 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-01-05 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2022-09-16 | 개시 | KeyBanc Capital Markets | Overweight |
| 2022-09-07 | 개시 | Truist | Buy |
| 2021-12-02 | 개시 | Jefferies | Buy |
| 2021-11-22 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2021-09-30 | 개시 | Berenberg | Buy |
| 2021-08-12 | 개시 | Barclays | Overweight |
| 2021-06-02 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2021-04-29 | 재개 | JP Morgan | Overweight |
| 2021-03-10 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2020-07-01 | 개시 | SVB Leerink | Outperform |
| 2020-06-02 | 개시 | Guggenheim | Buy |
| 2019-11-19 | 개시 | Citigroup | Buy |
| 2019-11-19 | 개시 | Goldman | Buy |
| 2019-11-19 | 개시 | JP Morgan | Overweight |
| 2019-11-19 | 개시 | Piper Jaffray | Overweight |
| 2019-11-19 | 개시 | SVB Leerink | Outperform |
모두보기
Progyny Inc 주식(PGNY)의 최신 뉴스
Can Progyny Inc. stock sustain revenue growthWeekly Stock Analysis & Smart Investment Allocation Insights - newser.com
New Men’s Health Research from Progyny Challenges Conventional Beliefs about Fertility Knowledge and Action - The Manila Times
Progyny (Nasdaq: PGNY) Study: 46% of Men With Fertility Issues Seek Support - Stock Titan
Insider Spends US$1.9m Buying More Shares In Progyny - Yahoo Finance
Insider Sell: Mark Livingston Sells Shares of Progyny Inc (PGNY) - GuruFocus
Progyny Insider Sold Shares Worth $543,227, According to a Recent SEC Filing - MarketScreener
CFO Livingston Sells 21,303 ($543.2K) Of Progyny Inc [PGNY] - TradingView
Visual analytics tools that track Progyny Inc. performancePortfolio Update Summary & AI Enhanced Trading Signals - newser.com
Norman Payson At Progyny Executes Options Exercise, Realizing $876K - Benzinga
Progyny: Growth Has Returned (Rating Upgrade) (NASDAQ:PGNY) - Seeking Alpha
How Progyny Inc. stock reacts to global recession fearsEarnings Miss & Advanced Swing Trade Entry Alerts - newser.com
How hedge fund analytics apply to Progyny Inc. stockQuarterly Trade Review & High Win Rate Trade Tips - newser.com
Is Progyny Inc. stock resilient to inflationJuly 2025 Price Swings & Accurate Trade Setup Notifications - newser.com
Can Progyny Inc. stock resist market sell offs2025 Earnings Impact & Reliable Breakout Stock Forecasts - newser.com
How high can Progyny Inc. stock goJuly 2025 Outlook & Comprehensive Market Scan Reports - newser.com
What MACD and RSI say about Progyny Inc.2025 AllTime Highs & Intraday High Probability Alerts - newser.com
Progyny at Jefferies London Conference: Fertility Benefits Expansion By Investing.com - Investing.com India
Progyny, Inc. (PGNY) Hit a 52 Week High, Can the Run Continue? - Yahoo Finance
A Look Back at Health Insurance Providers Stocks’ Q3 Earnings: Progyny (NASDAQ:PGNY) Vs The Rest Of The Pack - Yahoo Finance
Progyny (PGNY): Gauging Valuation After Recent Share Price Momentum - Yahoo Finance
Canaccord Genuity Maintains Progyny (PGNY) Hold Recommendation - Nasdaq
Progyny’s SWOT analysis: fertility benefits stock poised for growth amid regulatory changes - Investing.com Nigeria
Progyny (PGNY) CEO Increases Stake, Shares Surge 11% - GuruFocus
Progyny Shares Rise After CEO Anevski Buys $1.9 Million Worth of Shares - MarketScreener
Progyny CEO buys $1.93M in company stock - MSN
Progyny (PGNY) Sees Stock Surge After CEO's Significant Share Pu - GuruFocus
Progyny Insider Bought Shares Worth $1,930,896, According to a Recent SEC Filing - MarketScreener
Progyny stock hits 52-week high at 26.78 USD By Investing.com - Investing.com Australia
Progyny Shares Surge Amid Strong Financial Performance - TipRanks
Eye On Growth: Peter Anevski Adds $1.93M Of Progyny Stock To Portfolio - Benzinga
Progyny, Inc. Stock (PGNY) Opinions on Strong Q3 Earnings and Buyback Announcement - Quiver Quantitative
Anevski Peter, Progyny CEO, buys $1.93 million in PGNY stock By Investing.com - Investing.com Nigeria
Progyny price target raised to $26 from $23 at Canaccord - TipRanks
A Look Back at Health Insurance Providers Stocks' Q3 Earnings: Progyny (NASDAQ:PGNY) Vs The Rest Of The Pack - Finviz
What analyst consensus says on Progyny Inc. stockPortfolio Value Report & AI Powered Market Trend Analysis - newser.com
Progyny, Inc. (NASDAQ:PGNY) Stocks Shoot Up 27% But Its P/E Still Looks Reasonable - 富途牛牛
Applying chart zones and confluence areas to Progyny Inc.Market Risk Analysis & Low Risk Investment Opportunities - newser.com
What technical charts say about Progyny Inc. stock2025 Technical Overview & Safe Capital Growth Tips - newser.com
Progyny Inc (PGNY) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Progyny Inc 주식 (PGNY) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Payson Norman | Director |
Nov 14 '25 |
Option Exercise |
1.45 |
36,224 |
52,525 |
56,954 |
2.46%
자본화:
|
볼륨(24시간):